HeartBeam's 3D ECG technology received FDA clearance for arrhythmia assessment in December last year. Last week, HeartBeam partnered with AccurKardia to enhance cardiac monitoring solutions ...

HeartBeam (NASDAQ: BEAT) announced it has received FDA 510(k) clearance for its flagship ECG system, a first-of-its-kind, credi ...

SANTA CLARA, Calif. - HeartBeam, Inc. (NASDAQ: BEAT), a medical technology firm with a market capitalization of $83.2 million, has received 510(k) clearance from the US Food and Drug Administration ...

How do ECG smartwatches work? Most watches have a built-in ECG sensor, that can take a spot reading of your heart rate rhythm. You start the app and then place your finger on a specific part of ...

Researchers identified a lipid that is involved in regulating cardiac ion channels, providing insights into possible mechanisms of cardiac arrhythmias in heart failure and a potential pathway for ...

HeartBeam’s synthesised 12-lead electrocardiogram (ECG) has met the clinical endpoints in the VALID-ECG pivotal study, assessing non-life-threatening arrhythmias. In the study, the mean ...